This clinical research study is evaluating an oral investigational medication for adolescents living with severe alopecia areata—an autoimmune condition that causes patchy hair loss on the scalp and other areas. The goal of the study is to understand how this treatment may impact teens who have not seen improvement with other options.
.png){kind=icon}
In-person visits available at select U.S. research centers, including Clarkston, MI.
.png){kind=icon}
For adolescents ages 12–17 with severe patchy hair loss from alopecia areata.
.png){kind=icon}
Participants may receive an oral investigational medication and study-related care.
.png){kind=icon}
Families may receive compensation for time and travel related to study participation.
All qualified participants will receive study-related medical care, health evaluations, and the investigational oral treatment at no cost. Support will be provided by a team of experienced research professionals. Compensation may be available for time and travel.
This is an opportunity to contribute to alopecia areata research and potentially help shape future treatments.
No, it is investigational and being studied for its effects and safety in adolescents with severe alopecia areata.
All study-related care, medication, and clinic visits are provided at no cost to participants.
Yes, participation is completely voluntary and can be discontinued at any time.
